Processa Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule
February 06, 2024 08:30 ET
|
Processa Pharmaceuticals, Inc.
HANOVER, MD, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next...
MICT Regains Compliance with Nasdaq Minimum Bid Price Rule
December 15, 2022 14:00 ET
|
MICT, Inc.
MONTVALE, NJ, Dec. 15, 2022 (GLOBE NEWSWIRE) -- MICT, Inc. (NASDAQ: MICT) (“MICT”) announced today that it has received a Bid Price Compliance Letter from The Nasdaq Stock Market LLC ("Nasdaq")...